These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16316960)

  • 1. Apolipoprotein B versus non-high-density lipoprotein cholesterol: and the winner is..
    Sniderman AD
    Circulation; 2005 Nov; 112(22):3366-7. PubMed ID: 16316960
    [No Abstract]   [Full Text] [Related]  

  • 2. Weighing in before the fight: low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy.
    Denke MA
    Circulation; 2005 Nov; 112(22):3368-70. PubMed ID: 16316961
    [No Abstract]   [Full Text] [Related]  

  • 3. Advanced lipoprotein testing: recommendations based on current evidence.
    Lau JF; Smith DA
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):1-31. PubMed ID: 19217510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I--new risk factors and targets for therapy.
    Walldius G; Jungner I
    Nutr Metab Cardiovasc Dis; 2007 Oct; 17(8):565-71. PubMed ID: 17631989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.
    Miller M; Ginsberg HN; Schaefer EJ
    Am J Cardiol; 2008 Apr; 101(7):1003-8. PubMed ID: 18359322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apolipoprotein B and LDL cholesterol: which parameter(s) should be included in the assessment of cardiovascular risk?].
    Bloch S; Couderc R
    Ann Biol Clin (Paris); 1998; 56(5):539-44. PubMed ID: 9769484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy.
    Feeman WE
    Circulation; 2003 May; 107(20):e199. PubMed ID: 12777330
    [No Abstract]   [Full Text] [Related]  

  • 8. [The cholesterol contained in low-density lipoproteins or apolipoprotein B in the prediction of cardiovascular risk?].
    Vella Ramírez JC
    Rev Sanid Hig Publica (Madr); 1992; 66(5-6):251-5. PubMed ID: 1366222
    [No Abstract]   [Full Text] [Related]  

  • 9. The association of apolipoprotein B and low density lipoprotein with cardiovascular risk factors in the Thai population.
    Krittayaphong R; Chotinaiwatarakul C; Kangkagate C; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S1-7. PubMed ID: 17722296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Semiologic value of LDL cholesterol and apolipoprotein B in risk of atherosclerosis].
    Frey J; Couderc R
    Ann Biol Clin (Paris); 1998; 56(5):517-20. PubMed ID: 9769517
    [No Abstract]   [Full Text] [Related]  

  • 11. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
    Barter PJ; Ballantyne CM; Carmena R; Castro Cabezas M; Chapman MJ; Couture P; de Graaf J; Durrington PN; Faergeman O; Frohlich J; Furberg CD; Gagne C; Haffner SM; Humphries SE; Jungner I; Krauss RM; Kwiterovich P; Marcovina S; Packard CJ; Pearson TA; Reddy KS; Rosenson R; Sarrafzadegan N; Sniderman AD; Stalenhoef AF; Stein E; Talmud PJ; Tonkin AM; Walldius G; Williams KM
    J Intern Med; 2006 Mar; 259(3):247-58. PubMed ID: 16476102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
    St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
    Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II.
    Ballantyne CM; Bertolami M; Hernandez Garcia HR; Nul D; Stein EA; Theroux P; Weiss R; Cain VA; Raichlen JS
    Am Heart J; 2006 May; 151(5):975.e1-9. PubMed ID: 16644314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction: Apolipoproteins and guidelines for prevention of cardiovascular disease.
    Faergeman O
    J Intern Med; 2006 May; 259(5):434-6. PubMed ID: 16629848
    [No Abstract]   [Full Text] [Related]  

  • 15. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
    Langsted A; Freiberg JJ; Nordestgaard BG
    Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why are lipids not predictive of cardiovascular death in the dialysis patient?
    Ritz E
    Miner Electrolyte Metab; 1996; 22(1-3):9-12. PubMed ID: 8676835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?
    Jungner I; Sniderman AD; Furberg C; Aastveit AH; Holme I; Walldius G
    Am J Cardiol; 2006 Apr; 97(7):943-6. PubMed ID: 16563891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should advanced lipoprotein testing be used in clinical practice?
    Stein JH; McBride PE
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):640-1. PubMed ID: 17122792
    [No Abstract]   [Full Text] [Related]  

  • 19. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
    Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
    Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dyslipidemia and other cardiovascular risks: the Bogalusa Heart Study.
    Srinivasan SR; Frontini MG; Xu J; Berenson GS
    Pediatrics; 2006 Jul; 118(1):201-6. PubMed ID: 16818566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.